Table 1.

TRIM24/TIF1-α mRNA Levels in 238 Tumors

	No.	(%)	TRIM24 mRNA levels
			Median	Range	P⁎
N
N0	119	(50.0)	0.97	(0.80; 1.33)	0.756
N+	119	(50.0)	0.98	(0.75; 1.22)
T
T1 (≤2 cm)	122	(51.3)	0.98	(0.75; 1.15)	0.397
T2-T3-T4 (>2 cm)	116	(48.7)	0.98	(0.77; 1.33)
ER
ER−	58	(24.4)	1.02	(0.80; 1.22)	0.003
ER+	180	(75.6)	0.97	(0.75; 1.33)
Grade SBR
I	57	(24.0)	0.95	(0.80; 1.12)	0.003
II	86	(36.1)	0.98	(0.75; 1.33)
III	95	(39.9)	1.00	(0.78; 1.22)
Type/Sorlie
Normal like	24	(10.1)	0.95	(0.80; 1.07)	<0.001
Luminal A	100	(42.0)	0.96	(0.75; 1.33)
Luminal B	41	(17.2)	1.00	(0.78; 1.13)
Erbb2	30	(12.6)	1.00	(0.80; 1.13)
Basal	43	(18.1)	1.04	(0.85; 1.23)
70-gene
Good	90	(37.8)	0.95	(0.75; 1.12)	<0.001
Poor	148	(62.2)	1.00	(0.77; 1.33)
Two-gene ratio
High	131	(55.0)	0.98	(0.75; 1.22)	0.699
Low	107	(45.0)	0.98	(0.80; 1.33)
Wound response
Activated	189	(79.4)	0.98	(0.75; 1.33)	0.179
Quiescent	49	(20.6)	0.97	(0.80; 1.12)
Recurrence
High	153	(64.3)	1.00	(0.77; 1.33)	0.001
Intermediate	26	(10.9)	0.93	(0.75; 1.18)
Low	59	(24.8)	0.96	(0.80; 1.12)

^⁎Kruskall-Wallis test.

The 238 tumor samples used are from Fan et al.¹⁶